Showing results (401-410 of 484) with videos related to
Sort By:
Pageof 49
Journal of Neuro-Oncology|January 8, 2021
Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastasesMichael Zhang, Adrian J Rodrigues, Erqi L Pollom, et al.Translational Lung Cancer Research|July 14, 2022
Clinicopathological characteristics and prognostic significance of HDAC11 protein expression in non-small cell lung cancer: a retrospective studyDi Lu, Zhiqiang Ma, Di Huang, et al.Proceedings of the National Academy of Sciences of the United States of America|January 22, 2015
Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancerRebecca S Heist, Dan G Duda, Dushyant V Sahani, et al.Lung Cancer (Amsterdam, Netherlands)|September 16, 2025
Clinical factors and molecular co-alterations impact outcomes in patients receiving first-line osimertinib for EGFR-mutated non-small cell lung cancerFangdi Sun, Mandeep K Banwait, Surbhi Singhal, et al.Nature Medicine|April 8, 2014
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverageAaron M Newman, Scott V Bratman, Jacqueline To, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2026
First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non-Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 StudyJhanelle E Gray, Joel W Neal, Jyoti D Patel, et al.British Journal of Cancer|July 19, 2012
A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumoursI Diaz-Padilla, L L Siu, M San Pedro-Salcedo, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 21, 2023
Pulmonary Hemorrhage in Patients Treated With Thoracic Stereotactic Ablative Radiotherapy and Antiangiogenic AgentsBrianna C Lau, Yufan F Wu, Hyunsoo J No, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 31, 2025
First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS Less Than 50% and More Than or Equal to 50% Cohorts of the EVOKE-02 StudyMartin Reck, Jyoti D Patel, Jhanelle E Gray, et al.JAMA Network Open|November 15, 2023
Second Primary Lung Cancer Among Lung Cancer Survivors Who Never SmokedEunji Choi, Chloe C Su, Julie T Wu, et al.Pageof 49